SMS Pharmaceuticals Ltd Share Price ₹383

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of SMS Pharmaceuticals Ltd

Quarter-by-quarter operating performance

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales +	149	135	167	161	246	164	197	173	248	196	242	210	238
Expenses +	126	109	139	133	212	131	165	140	207	157	194	167	198
Operating Profit	23	27	28	29	33	33	32	33	41	39	48	44	40
OPM %	16%	20%	17%	18%	14%	20%	16%	19%	17%	20%	20%	21%	17%
Other Income +	1	1	1	1	2	1	1	2	1	1	1	4	3
Interest	6	6	6	6	6	5	5	4	5	6	6	6	5
Depreciation	8	8	8	8	8	8	9	9	9	10	10	10	10
Profit before tax	11	13	15	16	22	22	20	23	29	24	34	31	27
Tax %	24%	29%	21%	26%	26%	25%	28%	24%	29%	24%	26%	25%	23%
Net Profit +	8	9	12	12	16	16	14	17	21	18	25	23	21
EPS in Rs	0.95	1.10	1.42	1.44	1.88	1.93	1.68	2.03	2.33	2.05	2.68	2.49	2.23

Financials of SMS Pharmaceuticals Ltd

Annual income statement trend

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales +	587	611	438	463	465	412	563	520	522	709	783	887
Expenses +	500	522	363	369	375	332	442	405	467	592	643	716
Operating Profit	86	89	75	93	90	80	121	115	55	117	140	171
OPM %	15%	15%	17%	20%	19%	19%	22%	22%	10%	16%	18%	19%
Other Income +	16	4	1	2	3	5	3	5	5	4	6	8
Interest	18	17	16	15	12	12	11	19	22	24	19	23
Depreciation	17	19	19	20	19	22	22	32	32	32	34	40
Profit before tax	67	56	42	60	62	51	91	69	6	66	93	116
Tax %	48%	26%	14%	33%	34%	36%	33%	1%	26%	25%	27%	25%
Net Profit +	35	42	36	40	41	33	61	68	4	49	68	88
EPS in Rs	4.15	4.92	4.20	4.78	4.89	3.86	7.20	8.03	0.48	5.83	7.71	9.35
Dividend Payout %	5%	4%	5%	5%	5%	6%	4%	4%	62%	7%	5%	4%

Financials of SMS Pharmaceuticals Ltd

Capital structure and asset base

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	8	8	8	8	8	8	8	8	8	8	9	9
Reserves	246	286	254	293	331	359	420	485	487	562	664	795
Borrowings +	167	204	149	146	144	157	255	263	254	281	311	365
Other Liabilities +	119	158	89	72	93	103	147	126	165	217	202	211
Total Liabilities	540	656	501	519	577	627	830	883	914	1,068	1,186	1,381
Fixed Assets +	277	370	290	279	281	280	457	438	412	437	533	534
CWIP	29	13	8	8	18	42	7	11	33	30	35	116
Investments	13	21	37	45	45	45	45	45	45	45	45	52
Other Assets +	221	252	166	187	232	259	321	389	424	556	573	679
Total Assets	540	656	501	519	577	627	830	883	914	1,068	1,186	1,381

Financials of SMS Pharmaceuticals Ltd

Operating, investing and financing cash movement

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	59	61	73	32	50	40	90	45	22	50	82	61
Cash from Investing Activity +	-55	-79	-39	-17	-35	-43	-152	-27	-30	-52	-123	-132
Cash from Financing Activity +	-10	27	-33	-15	-13	-2	92	-12	-32	31	47	76
Net Cash Flow	-6	9	1	0	2	-5	31	6	-39	29	5	4
Free Cash Flow	11	-27	50	23	15	-3	-61	18	-7	-2	-42	-64
CFO/OP	75%	93%	110%	46%	70%	65%	88%	52%	49%	56%	73%	50%

Financials of SMS Pharmaceuticals Ltd

Working capital efficiency and return ratios

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	37	36	18	19	20	43	68	34	104	122	95	89
Inventory Days	81	106	114	135	170	191	148	333	243	201	238	259
Days Payable	58	79	82	49	59	66	70	97	117	130	95	89
Cash Conversion Cycle	61	63	50	105	131	169	146	270	230	192	238	259
Working Capital Days	19	19	-2	27	39	57	48	94	104	85	88	98
ROCE %	21%	16%	13%	18%	16%	13%	17%	12%	4%	11%	12%	13%